Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Combination of Cytidine and Omega-3 Fatty Acids in Bipolar Disorder
NCT00854737Phase 2Completed
- Sponsor
- McLean Hospital
- Start
- Jul 2004
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Cytidine in bipolar disorder (BD) (3 arms), sponsored by McLean Hospital. Primary endpoint: Mood Rating Scale Scores. Started Jul 2004; status: completed.
02
Drugs
Cytidine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00854737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00854737.